Global talent leader WilsonHCG announces integration of Profile and Personify brands
TAMPA, Fla., May 16, 2023 (GLOBE NEWSWIRE) -- WilsonHCG, a global talent solutions leader, is pleased to announce that two of its brands, Profile Search & Selection (Profile) and Personify, are being fully integrated into WilsonHCG in the coming weeks.
The integration follows the acquisitions of Profile and Personify, which closed in 2020 and 2023, respectively. Profile is an executive search firm with offices throughout Asia. Personify is an RPO provider that specializes in life sciences, healthcare, biotech and pharmaceuticals.
This is a significant step for WilsonHCG as it continues to expand its global market presence and breadth of talent solution offerings.
“We’re looking forward to this final stage of the integration as we bring the Profile and Personify brands into WilsonHCG,” said John Wilson, CEO of WilsonHCG. “It’s clear our combined capabilities have strengthened the organization and contributed to our success. To reinforce our market position and continue thriving, we will further integrate the brands externally.”
Following the integration, clients of Profile and Personify will receive the same high-quality talent solutions they’ve come to expect.
“We are excited for the opportunities that lie ahead,” said Andrew Oliver, co-founder of Profile and now EVP, head of Asia Pacific, at WilsonHCG. “Our combined expertise will propel us to new heights in the APAC region.”
Ryan Carfley, founder of Personify and now SVP, delivery at WilsonHCG, added, “This integration will give our clients access to a broader range of talent solutions. I’m thankful to be part of this chapter in WilsonHCG’s history and see what we’re able to accomplish from here.”
The integration of Personify will be completed by May 26, and the integration of Profile will be completed later this year. Personify’s executive search division, Mackenzie Ryan, will also be part of the brand integration.
For more information, please visit www.wilsonhcg.com.
About WilsonHCG
WilsonHCG is an award-winning, global leader in total talent solutions. Operating as a strategic partner, it helps some of the world’s most admired brands build comprehensive talent functions. With a global presence spanning more than 65 countries and six continents, WilsonHCG provides a full suite of configurable services including recruitment process outsourcing (RPO), executive search, contingent talent and talent consulting.
TALENT. ™ It’s more than a solution, it’s who we are.
Media contact
Kirsty Hewitt
+44 7889901517
813-418-4479
kirsty.hewitt@wilsonhcg.com
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed1.6.2023 06:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed Schweiter Technologies is increasing its 40% minority holding by taking over the remaining 60% of the stock. The agreement to purchase the rest of the shares in JMB Wind Engineering (“JMB”) has been signed and completed, further strengthening the Core Materials business of 3A Composites. Steinhausen, 1 June 2023 – JMB (www.jmbwind.com) is a leading developer and producer of core material kits – primarily balsa and PET products for wind turbines. It is headquartered in Goleniów, Poland and has subsidiaries in Poland, Portugal and Brazil. The company acquired has approximately 430 employees and achieved sales of around EUR 70 million in the 2022 business year. Schweiter Technologies acquired a 40% share of JMB in 2021 to establish a strategic partnership with a leading European kitting company. The acquisition of the remaining holding in JMB and the
SET Launches New Trading System Leveraging Nasdaq Technology to Meet End-to-End Investment Needs1.6.2023 04:00:00 CEST | Press release
BANGKOK, Thailand and NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- The Stock Exchange of Thailand (SET) has successfully launched its new trading system, together with market data distribution and market surveillance systems, based on Nasdaq (Nasdaq: NDAQ) technology. All systems are running seamlessly and operating at full efficiency in line with international standards and best practice. This newly developed state-of-the-art solution will support increasing transaction volumes and a variety of innovative investment products, whilst further enhancing the trust and integrity of the market. This implementation marks a significant milestone in the ongoing development of the modern Thai capital market, established to promote economic growth and stability, and to develop people’s standard of living. Today, SET has the highest liquidity among ASEAN exchanges, a position the exchange has held for more than 10 years. In 2022, capital raised through IPOs totaled 3.46 billion USD, the highest in
Havila Kystruten AS: Sustainability Report 2022 and Human Rights and Transparency Act 20221.6.2023 00:00:32 CEST | Press release
Please find attaced the - Sustainability Report 2022 - Human Rights and Transparency Act 2022 Attachments HKY - Sustainability Report 2022HKY Human Rights and Transparency Act 2022
Santhera Publishes Annual Report 202231.5.2023 23:50:39 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May31, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2022 with fully audited results for the year ended December 31, 2022. Santhera’s Annual Report 2022 provides comprehensive and detailed information on the Company, its strategy, business, financial performance, governance and compensation in 2022, and confirms the preliminary unaudited 2022 annual results which were published on April 27, 2023. The Annual Report 2022 is available for download on the Company’s website at www.santhera.com/financial-reports. Corporate calendar June 27, 2023 Annual General Meeting About Santhera Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need. The Company has an exclusive license for all indications worldwide to vamor
Havila Kystruten AS: Årsrapport 2022 med Revisors rapport31.5.2023 23:30:41 CEST | Pressemelding
Vedlagt følger selskapets årsrapport og revisors rapport for 2022. Ordinær generalforsamling holdes 16. juni 2023. Innkalling og agenda sendes 2. juni 2023. Kontakter: Administrerende direktør Bent Martini, +47 905 99 650 Finansdirektør Arne Johan Dale, +47 909 87 706 Vedlegg HKY_2022_Annual Report